Tirzepatide represents a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://tamzinnpst620979.blog2news.com/41073172/tirzepatide-a-game-changer-for-type-2-diabetes